findmyKOL
Clinical trialNCT00129337CompletedPhase 1Interventional

Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies

SponsorPeregrine PharmaceuticalsEnrollment28Tumors
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine the safety of bavituximab when administered via a vein, and to examine how bavituximab behaves in the body - how quickly it is taken up by the body and how long it stays there. The effect of bavituximab on tumor responses will also be examined.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Arizona Cancer Center

    Tucson, Arizona, United States

  • Premiere Oncology

    Santa Monica, California, United States

  • the West Clinic

    Memphis, Tennessee, United States

  • University of Texas Southwestern Medical Center

    Dallas, Texas, United States

  • Md Anderson Cancer Center

    Houston, Texas, United States

  • Scott & White Hospital, Center for Cancer Prevention and Care

    Temple, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Bavituximab
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2005
Primary completion
31 Aug 2009
Completion
31 Aug 2009
Last update posted
1 Mar 2011
Registered enrollment
28
Registry id
NCT00129337
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.